These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 20406101)

  • 1. The actin-cytoskeleton pathway and its potential role in inflammatory bowel disease-associated human colorectal cancer.
    Kanaan Z; Qadan M; Eichenberger MR; Galandiuk S
    Genet Test Mol Biomarkers; 2010 Jun; 14(3):347-53. PubMed ID: 20406101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of gene expression by cDNA microarray in human colorectal cancer tissues and normal mucosa.
    Bianchini M; Levy E; Zucchini C; Pinski V; Macagno C; De Sanctis P; Valvassori L; Carinci P; Mordoh J
    Int J Oncol; 2006 Jul; 29(1):83-94. PubMed ID: 16773188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical analysis of HNF4A and β-catenin expression to predict low-grade dysplasia in the colitis-neoplastic sequence.
    He Y; Chen L; Chen K; Sun Y
    Acta Biochim Biophys Sin (Shanghai); 2021 Jan; 53(1):94-101. PubMed ID: 33300557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic changes in the expression of MicroRNA-31 during inflammatory bowel disease-associated neoplastic transformation.
    Olaru AV; Selaru FM; Mori Y; Vazquez C; David S; Paun B; Cheng Y; Jin Z; Yang J; Agarwal R; Abraham JM; Dassopoulos T; Harris M; Bayless TM; Kwon J; Harpaz N; Livak F; Meltzer SJ
    Inflamm Bowel Dis; 2011 Jan; 17(1):221-31. PubMed ID: 20848542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphological, immunohistochemical and molecular features of inflammatory bowel disease associated colorectal carcinoma and associated mucosal lesions - Single institution experience.
    Kamarádová K; Vošmiková H; Rozkošová K; Ryška A; Tachecí I; Laco J
    Pathol Res Pract; 2019 Apr; 215(4):730-737. PubMed ID: 30679085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and Epigenetic Characteristics of Inflammatory Bowel Disease-Associated Colorectal Cancer.
    Rajamäki K; Taira A; Katainen R; Välimäki N; Kuosmanen A; Plaketti RM; Seppälä TT; Ahtiainen M; Wirta EV; Vartiainen E; Sulo P; Ravantti J; Lehtipuro S; Granberg KJ; Nykter M; Tanskanen T; Ristimäki A; Koskensalo S; Renkonen-Sinisalo L; Lepistö A; Böhm J; Taipale J; Mecklin JP; Aavikko M; Palin K; Aaltonen LA
    Gastroenterology; 2021 Aug; 161(2):592-607. PubMed ID: 33930428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulation of IL6/IL6R-STAT3-SOCS3 signaling pathway in IBD-associated colorectal dysplastic lesions as compared to sporadic colorectal adenomas in non-IBD patients.
    Gui X; Iacucci M; Ghosh S
    Pathol Res Pract; 2020 Nov; 216(11):153211. PubMed ID: 32979687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory bowel disease in Ashkenazi Jews: implications for familial colorectal cancer.
    Lynch HT; Brand RE; Locker GY
    Fam Cancer; 2004; 3(3-4):229-32. PubMed ID: 15516846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The histological diagnosis of dysplastic and neoplastic lesions in inflammatory bowel disease: a pathological perspective.
    Usaj S; Tarabar D; Cuk V; Cerovic S; Brajukovic G; Panisic M; Klem I; Eric Z
    Acta Chir Iugosl; 2004; 51(2):109-16. PubMed ID: 15771301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-224 negatively regulates p21 expression during late neoplastic progression in inflammatory bowel disease.
    Olaru AV; Yamanaka S; Vazquez C; Mori Y; Cheng Y; Abraham JM; Bayless TM; Harpaz N; Selaru FM; Meltzer SJ
    Inflamm Bowel Dis; 2013 Mar; 19(3):471-80. PubMed ID: 23399735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical expression of SP-NK-1R-EGFR pathway and VDR in colonic inflammation and neoplasia.
    Isidro RA; Cruz ML; Isidro AA; Baez A; Arroyo A; González-Marqués WA; González-Keelan C; Torres EA; Appleyard CB
    World J Gastroenterol; 2015 Feb; 21(6):1749-58. PubMed ID: 25684939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical expression of CDX2, β-catenin, and TP53 in inflammatory bowel disease-associated colorectal cancer.
    Laurent C; Svrcek M; Flejou JF; Chenard MP; Duclos B; Freund JN; Reimund JM
    Inflamm Bowel Dis; 2011 Jan; 17(1):232-40. PubMed ID: 20815042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic regulation of WNT signaling pathway genes in inflammatory bowel disease (IBD) associated neoplasia.
    Dhir M; Montgomery EA; Glöckner SC; Schuebel KE; Hooker CM; Herman JG; Baylin SB; Gearhart SL; Ahuja N
    J Gastrointest Surg; 2008 Oct; 12(10):1745-53. PubMed ID: 18716850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of key lncRNAs in colorectal cancer progression based on associated protein-protein interaction analysis.
    Zhu H; Yu J; Zhu H; Guo Y; Feng S
    World J Surg Oncol; 2017 Aug; 15(1):153. PubMed ID: 28797257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of profilin 2 contributes to enhanced epithelial-mesenchymal transition and metastasis of colorectal cancer.
    Zhang H; Yang W; Yan J; Zhou K; Wan B; Shi P; Chen Y; He S; Li D
    Int J Oncol; 2018 Sep; 53(3):1118-1128. PubMed ID: 30015842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular profiling of ulcerative colitis-associated neoplastic progression.
    Colliver DW; Crawford NP; Eichenberger MR; Zacharius W; Petras RE; Stromberg AJ; Galandiuk S
    Exp Mol Pathol; 2006 Feb; 80(1):1-10. PubMed ID: 16277983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole blood ACTB, B2M and GAPDH expression reflects activity of inflammatory bowel disease, advancement of colorectal cancer, and correlates with circulating inflammatory and angiogenic factors: Relevance for real-time quantitative PCR.
    Bednarz-Misa I; Neubauer K; Zacharska E; Kapturkiewicz B; Krzystek-Korpacka M
    Adv Clin Exp Med; 2020 May; 29(5):547-556. PubMed ID: 32424999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetically regulated miR-145 suppresses colon cancer invasion and metastasis by targeting LASP1.
    Wang W; Ji G; Xiao X; Chen X; Qin WW; Yang F; Li YF; Fan LN; Xi WJ; Huo Y; Wen WH; Yang AG; Wang T
    Oncotarget; 2016 Oct; 7(42):68674-68687. PubMed ID: 27626692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WNT-pathway activation in IBD-associated colorectal carcinogenesis: potential biomarkers for colonic surveillance.
    Claessen MM; Schipper ME; Oldenburg B; Siersema PD; Offerhaus GJ; Vleggaar FP
    Cell Oncol; 2010 Jan; 32(4):303-10. PubMed ID: 20208143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genes regulated by Nkx2-3 in sporadic and inflammatory bowel disease-associated colorectal cancer cell lines.
    Yu W; Lin Z; Pastor DM; Hegarty JP; Chen X; Kelly AA; Wang Y; Poritz LS; Koltun WA
    Dig Dis Sci; 2010 Nov; 55(11):3171-80. PubMed ID: 20165982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.